Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Compared to Valsartan Monotherapy or Hydrochlorothiazide Monotherapy in Elderly (>70) With Mild-moderate Hypertension.
Public ClinicalTrials.gov record NCT00698646. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 16 Week Multi-center, Randomized, Double-blind Study to Evaluate Efficacy and Safety of Valsartan/Hydrochlorothiazide (HCTZ) Combination Therapy Compared to Patients Initiated With Valsartan Monotherapy or Hydrochlorothiazide (HCTZ) Monotherapy in Very Elderly Patients With Essential Hypertension
Study identification
- NCT ID
- NCT00698646
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Novartis Pharmaceuticals
- Industry
- Enrollment
- 384 participants
Conditions and interventions
Conditions
Interventions
- HCTZ Drug
- Valsartan Drug
- Valsartan + HCTZ Drug
Drug
Eligibility (public fields only)
- Age range
- 70 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 31, 2008
- Primary completion
- May 31, 2009
- Completion
- May 31, 2009
- Last update posted
- Apr 18, 2011
2008 – 2009
United States locations
- U.S. sites
- 20
- U.S. states
- 15
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigative site | Birmingham | Alabama | — | — |
| Investigative site | Phoenix | Arizona | — | — |
| Investigative Site | Escondido | California | — | — |
| Investigative site | Fresno | California | — | — |
| Investigative site | Huntington Park | California | — | — |
| Investigative Sites | Pismo Beach | California | — | — |
| Investigative site | Miami | Florida | — | — |
| Investigative site | Ormond Beach | Florida | — | — |
| Investigative site | Conyers | Georgia | — | — |
| Investigative Site | Lexington | Kentucky | — | — |
| Investigative site | Portland | Maine | — | — |
| Investigative site | Las Vegas | Nevada | — | — |
| Investigative site | Buffalo | New York | — | — |
| Investigative site | Shelby | North Carolina | — | — |
| Investigative site | Carlisle | Ohio | — | — |
| Investigative site | Oklahoma City | Oklahoma | — | — |
| Investigative site | Erie | Pennsylvania | — | — |
| Investigative Site | Greer | South Carolina | — | — |
| Investigative Site | Taylors | South Carolina | — | — |
| Investigative site | St. George | Utah | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00698646, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 18, 2011 · Synced May 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00698646 live on ClinicalTrials.gov.